News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor

Breast Density Advocate Nancy M. Cappello Passes Away

Cappello’s work to inform women about the risks of dense breast tissue led to density inform laws in 35 states

Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

November 15, 2018 — Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who could be called the founder of the breast density education movement in the U.S., on her passing on Nov. 15. A breast cancer survivor herself, Cappello passed away from secondary myelodyspastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments.

Cappello was diagnosed with stage 3C breast cancer in February 2004, just six weeks after her annual mammogram came up normal. Her doctor told her that the cancer was missed on the mammogram because she had dense fibroglandular breast tissue, a concept that was little-known among patients at that time. Dense breast tissue appears white on a traditional 2-D mammogram, which can mask cancers that also show up as white. Women with extremely dense breast tissue are five times more likely to have breast cancer compared to women with fatty breasts. 

Wanting to make sure other women had access to this critical information to make more informed decisions about their healthcare, Cappello founded the nonprofit organizations Are You Dense Inc. and Are You Dense Advocacy in 2008. The group’s aims are four-fold:

  1. Educate the public about breast health and the impact of dense breast tissue
  2. Improve the condition of those diagnosed with breast cancer through education
  3. Advocate changes to public policy about the prevention and treatment of breast cancer, including breast cancer screening guidelines
  4. Support new and existing research about the prevention and treatment of breast cancer and the causal and screening risks of dense breast tissue and its impact on advanced disease

One of the group’s most visible efforts has been working with state legislatures to enact laws requiring mammography facilities to inform patients about their breast density and the associated cancer risks. Cappello started with the legislature in her home state of Connecticut, playing an instrumental part in the passage of the first breast density inform law in 2009. Since then, 36 states have passed some form of density notification legislation, with others in progress. Are You Dense and Are You Dense Advocacy have also been working with Congress to enact a national density inform law that would allow greater standardization among the states.  

Cappello’s latest medical battles began in September, according to her own blog post on AreYouDense.org. She was admitted to the hospital after feeling increasingly weak, to the point where she could not stand or walk for more than 1 minute without sitting down. Three weeks later, the diagnosis of secondary MDS was confirmed following a bone marrow biopsy. She had been awaiting a bone marrow transplant after it was determined none of her three siblings were a match.

“I am on a quest to expose this best-kept secret of dense breast tissue to ensure that women with dense breast tissue receive screening and diagnostic measures to find cancer at its earliest stage — isn’t that the purpose of screening programs?” she wrote on the AreYouDense website.

"Nancy was the originator of the dense breast tissue movement starting in Connecticut then across the nation and around the world. We believe she alone and the legislation she helped craft in 36 states has saved many lives," said Donna Johnson, president of Are You Dense Inc. in a statement. "Nancy's work is not over. Are You Dense Inc. and Are You Dense Advocacy Inc. will continue to work on a national breast density notification law and work on the remaining states one by one."

“Nancy Cappello was the inspiration behind the first #BreastDensity legislation in Connecticut in 2009. She will continue to inspire us to question the status quo and strive to do better,” said Wendy Ingman, Ph.D., associate professor in breast biology and cancer at the University of Adelaide, Australia, on Twitter.

“We lost Nancy Cappello, founder of RU Dense, today due to complications related to treatment of bc [breast cancer]. A brave woman whose actions truly made a difference!” said Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre, and professor of medical biophysics and medical imaging, University of Toronto.

Click through the links below to see ITNtv interviews with Cappello, as well as pieces she contributed to the magazine.

VIDEO: The Impact of Breast Density Technology and Legislation

VIDEO: Personalized Breast Screening and Breast Density

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference

Fake News: Having Dense Breast Tissue is No Big Deal

The Manic World of Social Media and Breast Cancer: Gratitude and Grief

Related Content

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
The study found that DBN laws helped some women understand they had increased breast density, but not that breast density is associated with a higher risk of breast cancer or that dense breasts limit the ability of mammograms to detect cancer
News | Breast Density | January 09, 2020
January 9, 2020 — A new study suggests that state-mandated notifications on...